X-135906419-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001381902.1(SAGE1):c.604G>A(p.Val202Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,208,805 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001381902.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAGE1 | NM_001381902.1 | c.604G>A | p.Val202Ile | missense_variant | Exon 7 of 20 | ENST00000370709.4 | NP_001368831.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SAGE1 | ENST00000370709.4 | c.604G>A | p.Val202Ile | missense_variant | Exon 7 of 20 | 5 | NM_001381902.1 | ENSP00000359743.3 | ||
SAGE1 | ENST00000324447.8 | c.604G>A | p.Val202Ile | missense_variant | Exon 7 of 20 | 5 | ENSP00000323191.3 |
Frequencies
GnomAD3 genomes AF: 0.0000266 AC: 3AN: 112595Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 34763
GnomAD3 exomes AF: 0.0000167 AC: 3AN: 179519Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 64165
GnomAD4 exome AF: 0.0000356 AC: 39AN: 1096155Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 361665
GnomAD4 genome AF: 0.0000266 AC: 3AN: 112650Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 34828
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.604G>A (p.V202I) alteration is located in exon 7 (coding exon 6) of the SAGE1 gene. This alteration results from a G to A substitution at nucleotide position 604, causing the valine (V) at amino acid position 202 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at